Clinical Trial Update: HIV Reservoir Dynamics After Switching to Dolutegravir in Patients on a PI and 2 NRTI Based Regimen [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports on HIV reservoir dynamics after switching from a protease inhibitor plus two NRTIs to dolutegravir in virologically suppressed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dolutegravir (dolutegravir)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: HIV-1 | Phase 4 | Status: COMPLETED